HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$41.16
Day range
$40.88 - $42.03
Year range
$9.24 - $50.69
Market cap
2.25B USD
Avg Volume
640.64K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 37.34M | 69.97% |
Net income | -33.71M | -67.19% |
Net profit margin | — | — |
Earnings per share | -0.62 | -34.78% |
EBITDA | -35.85M | -67.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 384.39M | 112.34% |
Total assets | 397.29M | 103.55% |
Total liabilities | 69.42M | 27.02% |
Total equity | 327.87M | — |
Shares outstanding | 54.83M | — |
Price to book | 6.88 | — |
Return on assets | -22.86% | — |
Return on capital | -23.71% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -33.71M | -67.19% |
Cash from operations | -24.78M | -39.44% |
Cash from investing | -22.68M | 73.77% |
Cash from financing | 3.44M | 696.06% |
Net change in cash | -44.02M | 57.59% |
Free cash flow | -11.88M | -18.13% |
About
Founded
2016
Headquarters
Website
Employees
72